“…Recently, CD163 has been recognized as a new macrophage-related differentiation marker, which is more specific than the conventional histiocyte-related molecules [2,3,5]. HS is a rare neoplasm and, by our search, CD163 staining was evaluated in 28 cases as summarized in Table 1 [3,[5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]. There are several reports of HS patients arising from other neoplasms, such as acute lymphoblastic leukemia, chronic lymphocytic leukemia, malignant lymphoma, and germ cell tumor [13][14][15][16][20][21][22].…”